Cas 1151916-75-4,{[(6-amino-9-phenethyl-9H-purin-8-ylmethyl)-amino]-methyl}-phosphonic acid

1151916-75-4

Post Buying Request

Basic information

Product Name: {[(6-amino-9-phenethyl-9H-purin-8-ylmethyl)-amino]-methyl}-phosphonic acid
Synonyms: {[(6-amino-9-phenethyl-9H-purin-8-ylmethyl)-amino]-methyl}-phosphonic acid
CAS NO:1151916-75-4
Molecular Formula:
Molecular Weight: 362.328
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: {[(6-amino-9-phenethyl-9H-purin-8-ylmethyl)-amino]-methyl}-phosphonic acid(CAS DataBase Reference)
NIST Chemistry Reference: {[(6-amino-9-phenethyl-9H-purin-8-ylmethyl)-amino]-methyl}-phosphonic acid(1151916-75-4)
EPA Substance Registry System: {[(6-amino-9-phenethyl-9H-purin-8-ylmethyl)-amino]-methyl}-phosphonic acid(1151916-75-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1151916-75-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1151916-75-4 Suppliers

Recommended suppliers

1151916-75-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1151916-75-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,1,9,1 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1151916-75:
(9*1)+(8*1)+(7*5)+(6*1)+(5*9)+(4*1)+(3*6)+(2*7)+(1*5)=144
144 % 10 = 4
So 1151916-75-4 is a valid CAS Registry Number.

1151916-75-4Upstream product

1151917-19-9 diethyl {[(6-amino-9-phenethyl-9H-purin-8-ylmethyl)-amino]-methyl}-phosphonate

1151916-75-4Downstream Products

1151916-75-4Relevant academic research and scientific papers

Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics

Dang, Qun,Brown, Brian S.,Liu, Yan,Rydzewski, Robert M.,Robinson, Edward D.,Van Poelje, Paul D.,Reddy, M. Rami,Erion, Mark D.

experimental part, p. 2880 - 2898 (2010/02/28)

Inhibition of FBPase is considered a promising way to reduce hepatic gluconeogenesis and therefore could be a potential approach to treat type 2 diabetes. Herein we report the discovery of a series of purine phosphonic acids as AMP mimics targeting the AM

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1151916-75-4